Over the past decade, TF–miRNA FFLs have been widely used to identify the cancer-associated genes or miRNAs in many tumor types, such as NSCLC [16], glioblastoma [14], ovarian cancer [15] and T-cell acute lymphoblastic leukemia [17]. This evidence concerns the gene TF and glioblastoma.